PDCD1LG2 and pituitary tumor: We found higher expression of PD-L2, CD80, and CD86 in aggressive pituitary adenomas when compared to normal pituitary tissues, suggesting the accumulation of peripheral immune cells like regulatory T cells, NK cells and dendritic cells in the pituitary tumor immune microenvironment (TIME).